rs2243290 — IL4 IL4 Intron 3 Protective Haplotype Variant

IL4 Intron 3 Variant — The Protective Haplotype Anchor

Interleukin-4 (IL-4) is the master switch of the Th2 immune axis — it instructs naive T cells to differentiate into Th2 cells, drives B cells to switch antibody production to IgE, and sustains the eosinophil and mast cell responses that underlie asthma, atopic dermatitis, and allergic rhinitis. The rs2243290 variant¹¹ rs2243290 variant
An intronic single-nucleotide variant located within intron 3 of the IL4 gene on chromosome 5 does not alter the protein sequence, but it sits within a haplotype block that has measurable consequences for allergic disease susceptibility. Understanding this SNP requires understanding the haplotype it belongs to.

The Mechanism

rs2243290 is one of three variants that together define the IL4 protective C-G-C haplotype, alongside rs2243250²² rs2243250
The IL4 -589C>T promoter variant — the best-studied IL4 regulatory SNP, which alters NFAT-1 transcription factor binding affinity and rs2227284³³ rs2227284
An IL4 intron 2 variant whose GG genotype has independently shown protective effects against rhinoconjunctivitis. When all three loci carry their protective alleles (C at rs2243250, G at rs2227284, C at rs2243290), the resulting haplotype is associated with lower Th2 tone and reduced atopic risk. The intronic location of rs2243290 means it likely influences IL4 expression through regulatory mechanisms — possibly affecting pre-mRNA splicing efficiency, intronic enhancer activity, or chromatin state at the locus — rather than changing the protein. The precise molecular mechanism through which this specific intronic variant contributes to haplotype function has not been fully resolved in published literature; the evidence is haplotypic rather than mechanistically isolated to this SNP alone.

The Evidence

The most direct evidence for rs2243290 itself comes from a 2013 Japanese case-control study⁴⁴ 2013 Japanese case-control study
Miyake, Tanaka & Arakawa — J Investig Allergol Clin Immunol 2013; 89 asthmatic women, 1,281 controls. The AC genotype at rs2243290 was significantly associated with a reduced risk of asthma (adjusted OR 0.62, 95% CI 0.39–0.996) compared to the AA reference group. The CC genotype did not reach significance, likely because the C allele is rare in East Asian populations (~26%) — the study lacked power for the CC group. Notably, haplotype-level analyses including this SNP alongside rs2243250 and rs2227284 did not reach formal significance, suggesting the individual SNP signal may be partly independent of or partly redundant with the full haplotype.

A companion study of 393 rhinoconjunctivitis cases vs 703 controls⁵⁵ 393 rhinoconjunctivitis cases vs 703 controls
Miyake, Tanaka & Arakawa — Hum Immunol 2012 found no significant association with rs2243290 and allergic rhinitis, while rs2227284 GG remained protective (OR 0.60). This divergence in phenotype associations is consistent with the complex, tissue-specific nature of IL4 regulation in different allergic manifestations.

The broader context is that IL4 pathway variants combine additively and synergistically. A four-locus interaction study in 2,000 Han Chinese children⁶⁶ four-locus interaction study in 2,000 Han Chinese children
Li Hua et al., Pediatric Pulmonology 2016 found that children homozygous for risk alleles at IL4 rs2243250, IL13, FCER1B, and ADRB2 had OR 13.55 for asthma — illustrating how the cumulative Th2 haplotype burden, of which rs2243290 is one component, drives exponential risk escalation.

Practical Actions

For those carrying one or two A alleles at rs2243290, the practical significance depends on the broader IL4 haplotype context: AA homozygotes (common in East Asian populations but rare in Europeans) lack protective alleles at this intronic locus and, if they also carry the rs2243250 T allele and rs2227284 T allele, represent the highest-risk IL4 haplotype profile. Monitoring total serum IgE when allergic symptoms develop is the most clinically actionable response to this genotype. Quercetin — which demonstrably suppresses IL-4 transcription in activated T cells — has indirect mechanistic relevance since this intronic variant is part of the same regulatory architecture as the promoter variants that quercetin modulates.

Interactions

rs2243290 should be interpreted in concert with its haplotype partners: rs2243250 (IL4 -589C>T promoter, the primary Th2 amplification signal) and rs2227284 (IL4 intron 2, protective GG). The combination of risk alleles across these three loci (TT at rs2243250, TT at rs2227284, AA at rs2243290) defines the high-Th2 IL4 haplotype. Additionally, the downstream IL-4 receptor variant rs1801275 (IL4R Gln576Arg) and the IL-13 variant rs20541 (IL13 Arg130Gln) create additive Th2 amplification when present alongside IL4 haplotype risk alleles.